LivePerson Shares Drop Following Wider-Than-Expected Loss in Fourth Quarter

The digital-customer-technology company LivePerson experienced a significant decline in its shares, dropping 41% to $1.42 after reporting a fourth-quarter loss that surpassed analysts' expectations.

Financial Performance

LivePerson's quarterly loss amounted to $40.5 million, or 48 cents per share, compared to the previous year's loss of $41.7 million, or 55 cents per share. Although analysts projected a loss of $24.6 million, or 31 cents per share. Revenue for the quarter totaled $95.5 million, falling short of both last year's $122.5 million and analysts' expected $94.4 million.

Market Response

The stock reached its lowest point of $1.40 within the session, marking an 86% decline over the past 12 months.

Future Projections

In light of current financial outcomes, LivePerson anticipates revenue figures between $300 million to $315 million for 2024. For the first quarter of the year, the company projects revenues ranging from $79 million to $83 million. Analysts have set higher expectations with projected revenues of $339.1 million for the full year and $85.6 million for the first quarter.

Despite securing 62 deals in the fourth quarter, which included contracts with 16 new customers and 46 existing ones, LivePerson faces challenges in meeting financial targets.

For more updates on LivePerson's performance in the coming months, stay tuned.

Duolingo's Rapid Growth in 2023

Nasdaq Hits Record High

Leave A Reply

Your email address will not be published. Required fields are marked *

Related posts

Ezcorp Reports Strong First-Quarter Earnings, Shares Surge 12%
News

Ezcorp Reports Strong First-Quarter Earnings, Shares Surge 12%

Ezcorp reported strong first-quarter earnings, exceeding analyst expectations, leading to a 12% surge in shares. Read mo...

Lipella Pharmaceuticals Shares Skyrocket 52.2% After FDA Approval
News

Lipella Pharmaceuticals Shares Skyrocket 52.2% After FDA Approval

Lipella Pharmaceuticals' stock surges 52.2% following FDA approval of its investigational drug for oral lichen planus. C...

European Carmakers and Suppliers: Fourth-Quarter Earnings and 2024 Guidance
News

European Carmakers and Suppliers: Fourth-Quarter Earnings and 2024 Guidance

Analysts predict modest growth in global car sales for European carmakers, while challenges and key players continue to...

UK Regulator Begins Probe into Arcelik's Planned Merger with Whirlpool's European Appliances Business
News

UK Regulator Begins Probe into Arcelik's Planned Merger with Whirlpool's European Appliances Business

The UK regulator launches an investigation into the planned merger between Arcelik and Whirlpool, citing concerns about...